Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-β type II receptor using an infiltrator in porcine coronary arteries: Efficacy and complications

Experimental and Molecular Medicine

Volumn 34, Issue 4, 2002, Pages 299-307

  Chung, Ick Mo ^a   Ueno, Hikaru ^b   Pak, Youngmi Kim ^c   Kim, Joon Woo ^c   Choi, Dong Hoon ^c   Shin, Gil Ja ^a   Yang, Woo Ick ^d   Jang, Yang Soo ^c  

^a Ewha Womans University School of Medicine   (South Korea)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c Korea National Institute of Health   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Catheterization; Coronary restenosis; Extracellular matrix; Gene therapy; Local delivery; Transforming growth factor receptors

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CD3 ANTIGEN; FC RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1;

ADVENTITIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DILATATION; EXTRACELLULAR MATRIX; FEMALE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SWINE; T LYMPHOCYTE; TRANSGENE; VIRUS TITRATION;

ADENOVIRIDAE; ANIMALIA; SUIDAE; SUS SCROFA;

EID: 0037201420     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2002.42     Document Type: Article

References (36)

1. Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, Wrana JL. Identification of human activin and TGF type receptors that form heteromeric kinase complexes with type II receptors. Cell 1993;75:671-80
2. Barath P, Popov A, Dillehay GL, Matos G, McKierman. Infiltrator angioplasty balloon catheter: A device for combined angioplasty and intramural site-specific treatment. Cathet Cardiovasc Diagn 1997;41:333-41
3. Bassing CH, Yingling J, Howe DJ, Wang T, He WW, Gustafson ML, Shah P, Donahohe PK, Wang XF. A transforming growth factor β type I receptor that signals to activate gene expression. Science 1994;263:87-9
4. Chen RW, Ebner R, Derynck R. Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 1993;260:1335-8
5. Chung I-M, Gold HK, Schwartz SM, Ikan Y, Reidy MA, Wight TN. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 2002 (in press)
6. Danko I, Fritz JD, Jiao S, Hogan K, Latendresse JS, Wolff JA. Pharmacological enhancement of in vivo foreign gene expression in muscle. Gene Ther 1994;1:114-21
7. Dijike PT, Yamashita H, Ichijo, Franzen P, Laiho M, Miyazono K, Heldin C-H. Characterization of type I receptors for transforming growth factor β and activin. Science 1994;264:101-4
8. Feldman LJ, Steg PG, Zheng LP, Chen D, Kearney M, McGarr SE, Barry JJ, Dedieu J-F, Perricaudet M, isner JM. Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. J Clin Invest 1995;95:2662-71
9. Franzen P, Dijke PT, Ichijo H, Yamashita H, Schulz P, Heldin CH, Miyazano K. Cloning of TGF type receptor that forms a heteromeric complex with the TGF type II receptor. Cell 75:681-92
10. Gordon D, Reidy MA, Benditt EP, Schwarz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990;87:4600-4
11. Grubb BR, Pickles RJ, Ye H, Yankaskas JR, Vick RN, Engelhardt JF, Wilson JM, Johnson LG, Boucher RC. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature 1994;371;802-6
12. Kingston PA, Sinha S, David A, Castro MG, Lowenstein PR, Heagerty AM. Adenovirus-mediated gene transfer of a secreted transforming growth factor-β type II receptor inhibits luminal loss and constrictive remodeling after coronary angioplasty and enhances adventitial collagen deposition. Circulation 2001;104:2595-601
13. McCaffrey TA. TGF-betas and TGF-beta receptors in atherosclerosis. Cytokine Growth Factor Rev 2000;11:103-14
14. Morishige K, Shimokawa H, Yamawaki T, Miyata K, Eto Y, Kandabashi T, Yogo K, Higo T, Egashira K, Ueno H, Takeshita A. Local adenovirus-mediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo. J Am Coll Cardiol 2000;35:1040-7
15. Muller DW, Ellis SG, Topol EJ. Experimental models of coronary artery restenosis. J Am Coll Cardiol 1992;19:418-32
16. Nabel EG, Shum L, Pompili VJ, Yang Z, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, Nabel GJ. Direct transfer of transforming growth factor β1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA 1993;90:10759-63
17. Nikol S, Isner JM, Pickering G, Kemey M, Leclerc G, Weir L. Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions. J Clin Invest 1992;90:1582-92
18. OBrien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson J, Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. Circ Res 1993;73:223-31
19. Pavlides GS, Barath P, Maginas A, Vasilicos V, Cokkinos DV, ONeill WW. Intramural drug delivery by direct injection within the arterial wall: First clinical experience with a novel intracoronary delivery-infiltrator system. Cathet Cardiovasc Diagn 1997;41:287-92
20. Qi Z, Astuchi N, Ooshima A, Takeshita A, Ueno H. Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 1999;96:2345-9
21. Sakamoto T, Ueno H, Sonoda K, Hisatomi T, Shimizu K, Ohashi H, Inomata H. Blockade of TGF-β by in vivo gene transfer of a soluble TGF-β type II receptor in the muscle inhibits corneal opacification, edema and angiogenesis. Gene Therapy 2000;7:1915-24
22. Schönherr E, Järveläinen HT, Sandell LJ, Wight TN. Effects of platelet-derived growth factor and transforming growth factorbeta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J Biol Chem 1991;266:17640-7
23. Schönherr E, Järveläinen HT, Kinsella MG, Sandell LJ, Wight TN. Platelet-derived growth factor and transforming growth factor-beta 1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler Thromb 1993;13:1026-36
24. Schulick AH, Taylor AJ, Zuo W, Qiu CB, Dong G, Woodward RN, Agah R, Roberts AB, Virmani R, Dichek DA. Overexpression of transforming growth factor β 1 in arterial endothelium causes hyperplasia, apoptosis, and cartilaginous metaplasia. Proc Natl Acad Sci USA 1998;95:6983-8
25. Smith JD, Bryant SR, Couper LL, Vary CPH, Gotwals PJ, Koteliansky VE, Lindner V. Soluble transforming growth factor-β type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth. Circ Res 1999;84:1212-22
26. Strauss BH, Umans VA, Suylen R, Feyter PJ, Marco J, Robertson GC, Renkin J, Heyndrickx G, Vuzevski VD, Bosman FT, Serruys PW. Directional atherectomy for treatment of restenosis within coronary stents: Clinical, angiographic and histologic results. J Am Coll Cardiol 1992;20:1465-73
27. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AL, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994;75:650-8
28. Ueno H, Li JJ, Tomita H, Yamamoto H, Pan Y, Kanegae Y, Saito I, Takeshita A. Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries. Arterioscler Thromb Vasc Biol 1995;15:2246-53
29. Varenne O, Pislaru S, Gillinjns H, Pelt NV, Gerard RD, Zoldhelyi P, de Werf FV, Collen D, Jansen SP. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 1998;98:919-26
30. Wivel NA, Wilson JM. Methods of gene delivery. Gene Therapy 1998;12:483-501
31. Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-β1 suppress intimal hyperplasia in a rat model. J Clin Invest 1994;93:1172-8
32. Yamamoto H, Ueno H, Ooshima A, Takeshita A. Adenovirus-mediated transfer of a truncated transforming growth factor βP type II receptor completely and specifically abolishes diverse signaling by TGF-β in vascular wall cells in primary culture. J Biol Chem 1996;271:16253-9
33. Yamamoto K, Morishita R, Tomita N, Shimozata T, Nakagami H, Kikuchi A, Aoki M, Higashi J, Kaneda Y, Ogihara T. Ribozyme oligonucleotides against transforming growth factor-β inhibited neointimal formation after vascular injury in rat model. Potential application of ribozyme strategy to treat cardiovascular disease. Circulation 2000;102:1308-14
34. Yang Y, Ertl HC, Wilson JM. MHC class I-restricted cytotoxic lymphocytes to viral antigens destroy hepatocytes in mice infected with E1 deleted recombinant adenoviruses. Immunity 1994;1:433-42
35. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol 1995;69:2004-15
36. Yang Y, Haecker SE, Su Q, Wilson JM. Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum Mol Genet 1996;5:1703-12